PEAK PHARMACEUTICALS, INC. Business Development
PEAK PHARMACEUTICALS, INC. (RMHI) reported Business Development of $412.11 thousand for the 12-month period ending 2014-09-30, per its 10-K filed 2016-01-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessDevelopment · last filed 2016-01-13
- PEAK PHARMACEUTICALS, INC. business development for the quarter ending 2014-09-30 was -$30.00.
- PEAK PHARMACEUTICALS, INC. business development for the quarter ending 2014-06-30 was $0.00.
- PEAK PHARMACEUTICALS, INC. business development for the quarter ending 2014-03-31 was $5.00K.
- PEAK PHARMACEUTICALS, INC. business development for the quarter ending 2013-12-31 was $407.11K.
- PEAK PHARMACEUTICALS, INC. business development for fiscal 2014 was $412.11K.
| Period end | Business Development 3 month | Business Development 6 month | Business Development 9 month | Business Development 12 month |
|---|---|---|---|---|
| 2014-09-30 | -$30.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-01-13 | -$30.00 derived: sum of 2 quarters · filed 2016-01-13 | $4.97K derived: sum of 3 quarters · filed 2016-01-13 | $412.11K 10-K · filed 2016-01-13 |
| 2014-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-13 | $5.00K derived: sum of 2 quarters · filed 2015-08-13 | $412.14K 10-Q · filed 2015-08-13 | |
| 2014-03-31 | $5.00K 10-Q · filed 2015-05-15 | $412.14K 10-Q · filed 2015-05-15 | ||
| 2013-12-31 | $407.11K 10-Q · filed 2015-02-17 |